dihexa hgf c-met cancer risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Small molecule activation of the
Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma Downstream signalling and specific inhibition of c MET HGF pathway in small cell lung cancer: implications for tumour invasion British Journal of Cancer Activated HGF c Met Axis in Head and Neck Cancer Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




